SCHEMBL7474496

SCHEMBL7474496

COC(=O)c1ccc2c3c(n(Cc4cc5c(cc4Cl)OCO5)c2c1)C(=O)CC3

nearest known ligand 0.43

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MEN1 O00255 3/20 0.43
KMT2A Q03164 3/20 0.43
RXFP1 Q9HBX9 1/20 0.43
SLC22A12 Q96S37 1/20 0.40
SMN1; SMN2 Q16637 6/20 0.37
TSHR P16473 2/20 0.37
MAPK10 P53779 1/20 0.37
HIF1A Q16665 1/20 0.37
ALDH1A1 P00352 5/20 0.37
KDM4E B2RXH2 4/20 0.37
MAPK1 P28482 2/20 0.37
HTT P42858 2/20 0.37
HSD17B10 Q99714 2/20 0.37
GAA P10253 2/20 0.37
NPC1 O15118 3/20 0.36
RAB9A P51151 3/20 0.36
EDNRA P25101 2/20 0.36
L3MBTL1 Q9Y468 1/20 0.36
CASP3 P42574 1/20 0.36
SENP7 Q9BQF6 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7420612 0.95 ALDH1A1 (0.44) MEN1KMT2ARXFP1SLC22A12SMN1; SMN2
SCHEMBL7473906 0.89 ALDH1A1 (0.43) SLC22A12SMN1; SMN2TSHRALDH1A1KDM4E
SCHEMBL7476678 0.88 SLC22A12 (0.39) SLC22A12SMN1; SMN2TSHRALDH1A1KDM4E
SCHEMBL7470778 0.85 DPP4 (0.46) MEN1KMT2ARXFP1SMN1; SMN2ALDH1A1
SCHEMBL7426960 0.83 ALDH1A1 (0.51) SLC22A12SMN1; SMN2TSHRALDH1A1KDM4E
SCHEMBL7421878 0.82 KDM4E (0.41) SLC22A12SMN1; SMN2TSHRALDH1A1KDM4E
SCHEMBL7371677 0.80 ALDH1A1 (0.45) RXFP1SMN1; SMN2TSHRALDH1A1KDM4E
SCHEMBL7422984 0.79 DPP4 (0.47) MEN1KMT2ARXFP1TSHRALDH1A1
SCHEMBL7423537 0.76 MEN1 (0.40) MEN1KMT2ARXFP1SLC22A12SMN1; SMN2
SCHEMBL7429126 0.74 MEN1 (0.40) MEN1KMT2ARXFP1SLC22A12SMN1; SMN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0820441-B1 INDOLE DERIVATIVES AS cGMP-PDE INHIBITORS FUJISAWA PHARMACEUTICAL CO (JP) 2002-06-26 EP disclosed
US-6358992-B1 Method of inhibiting neoplastic cells with indole derivatives CELL PATHWAYS, INC. 2002-03-19 US disclosed
US-6069156-A Indole derivatives as cGMP-PDE inhibitors FUJISAWA PHARMACEUTICAL CO., LTD. (JP) 2000-05-30 US disclosed
EP-0820441-A1 INDOLE DERIVATIVES AS cGMP-PDE INHIBITORS FUJISAWA PHARMACEUTICAL CO., LTD. (JP) 1998-01-28 EP disclosed